drug interactions with glp-1 glp 1 medication Are there any interactions between (Glucagon-like peptide-1) receptor Table 5 from Glucagon-Like Peptide-1
Description
Inhibition of the hERG channel can cause fatal cardiac arrhythmias in humans ( 27 )
Food tolerability improves
J., & Obesity (2021)
GLP-1 quiets appetite
The clinical trials needed to establish safety and efficacy in this population are still underway
Two weeks after taking 0.5 mg, one patient reported she hadnt felt that well in a decade, was eating foods she hadnt been able to tolerate, was able to go to a restaurant again, and had even gone for a hike
